25 May 2013
Keywords: s-p, files, temodal, usa, schering-plough, filed, approval
Article | 20 August 1998
Schering-Plough has filed for approval in the USA to market itsanticancer drug Temodal (temozolomide) for the second-line treatment of adults ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.